ATE233756T1 - Kristalline form von omeprazol-natriumsalz - Google Patents

Kristalline form von omeprazol-natriumsalz

Info

Publication number
ATE233756T1
ATE233756T1 AT98931166T AT98931166T ATE233756T1 AT E233756 T1 ATE233756 T1 AT E233756T1 AT 98931166 T AT98931166 T AT 98931166T AT 98931166 T AT98931166 T AT 98931166T AT E233756 T1 ATE233756 T1 AT E233756T1
Authority
AT
Austria
Prior art keywords
sodium salt
crystalline form
omeprazole sodium
omeprazole
crystalline
Prior art date
Application number
AT98931166T
Other languages
English (en)
Inventor
Anders Gustavsson
Kristina Kjellbom
Ingvar Ymen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE233756T1 publication Critical patent/ATE233756T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98931166T 1997-06-27 1998-06-11 Kristalline form von omeprazol-natriumsalz ATE233756T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702483A SE510643C2 (sv) 1997-06-27 1997-06-27 Termodynamiskt stabil omeprazol natrium form B
PCT/SE1998/001124 WO1999000380A1 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt

Publications (1)

Publication Number Publication Date
ATE233756T1 true ATE233756T1 (de) 2003-03-15

Family

ID=20407555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98931166T ATE233756T1 (de) 1997-06-27 1998-06-11 Kristalline form von omeprazol-natriumsalz

Country Status (35)

Country Link
US (1) US6207188B1 (de)
EP (2) EP0991641B1 (de)
JP (1) JP3377218B2 (de)
KR (1) KR100580987B1 (de)
CN (1) CN1134432C (de)
AR (1) AR013350A1 (de)
AT (1) ATE233756T1 (de)
AU (1) AU750239B2 (de)
BR (1) BR9810483A (de)
CA (1) CA2294614C (de)
CZ (1) CZ296723B6 (de)
DE (1) DE69811892T2 (de)
DK (1) DK0991641T3 (de)
EE (1) EE03613B1 (de)
EG (1) EG24224A (de)
ES (1) ES2191944T3 (de)
HK (1) HK1026699A1 (de)
HU (1) HU227976B1 (de)
ID (1) ID24829A (de)
IL (2) IL133559A0 (de)
IS (1) IS1946B (de)
MY (1) MY127871A (de)
NO (1) NO318245B1 (de)
NZ (1) NZ501929A (de)
PL (1) PL190869B1 (de)
PT (1) PT991641E (de)
RU (1) RU2186778C2 (de)
SA (1) SA98190410B1 (de)
SE (1) SE510643C2 (de)
SK (1) SK283958B6 (de)
TR (1) TR199903270T2 (de)
TW (1) TW483758B (de)
UA (1) UA58556C2 (de)
WO (1) WO1999000380A1 (de)
ZA (1) ZA985317B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
WO1997025429A1 (en) 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
AU4198899A (en) * 1999-05-20 2000-12-12 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
AU5248601A (en) * 2000-05-15 2001-11-26 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts
CA2417311C (en) 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
US7396841B2 (en) 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
ES2348710T5 (es) * 2001-06-01 2014-02-17 Pozen, Inc. Composiciones farmacéuticas para el suministro coordinado de NSAID
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
EP1556043A1 (de) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Amorphe form von esomeprazol-magnesiumsalz
US20070060556A1 (en) * 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
CN103772360A (zh) 2004-06-24 2014-05-07 阿斯利康(瑞典)有限公司 制备用于制备艾美拉唑钠盐的结晶修饰物的新方法
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
WO2006131338A2 (en) * 2005-06-08 2006-12-14 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
CN101412710B (zh) * 2008-12-16 2010-04-21 海南百那医药发展有限公司 一种奥美拉唑钠化合物及其制法
NZ597534A (en) * 2009-06-25 2013-09-27 Pozen Inc Method for treating a patient in need of aspirin therapy
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102512380B (zh) * 2011-12-20 2013-04-17 海南锦瑞制药股份有限公司 一种以奥美拉唑钠为活性成分的冻干粉针剂及其制备方法
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
CN102827147B (zh) * 2012-09-13 2013-08-07 山东罗欣药业股份有限公司 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物
CN102871973A (zh) * 2012-10-16 2013-01-16 浙江亚太药业股份有限公司 一种奥美拉唑钠冻干制剂及其制备方法
CN103012371B (zh) * 2013-01-05 2014-02-12 宁辉 奥美拉唑钠结晶化合物、其制备方法及其药物组合物
CN103570687B (zh) * 2013-11-15 2015-01-07 悦康药业集团有限公司 一种奥美拉唑钠晶体化合物
CN104788426B (zh) * 2015-04-02 2015-12-30 天津大学 一种奥美拉唑钠半水合物及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification
CN116041325A (zh) * 2022-12-09 2023-05-02 山东北大高科华泰制药有限公司 稳定化质子泵抑制剂的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2719916C2 (de) * 1977-05-04 1987-03-19 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decanen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
ES2023778A6 (es) * 1990-12-12 1992-02-01 Genesis Para La Investigacion Procedimiento para preparar sales alcalinas del omeprazol
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
ATE414509T1 (de) 1994-07-08 2008-12-15 Astrazeneca Ab Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN1042423C (zh) * 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
AU5982198A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos
EP0968205A1 (de) * 1997-03-07 2000-01-05 A/S GEA Farmaceutisk Fabrik Verfahren zur herstellung von 2-[[(2-pyridinyl)methyl]sulfinyl]-1h-benzimidazolen und dabei verwendbare neue verbindungen
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
PL337735A1 (en) 2000-08-28
AU8135398A (en) 1999-01-19
CA2294614A1 (en) 1999-01-07
IL133559A (en) 2006-04-10
SK172999A3 (en) 2000-07-11
NO996440L (no) 2000-02-08
CZ296723B6 (cs) 2006-05-17
DK0991641T3 (da) 2003-05-19
EE03613B1 (et) 2002-02-15
DE69811892D1 (de) 2003-04-10
HU227976B1 (en) 2012-07-30
ES2191944T3 (es) 2003-09-16
HUP0003017A3 (en) 2002-01-28
DE69811892T2 (de) 2004-03-04
SE9702483D0 (sv) 1997-06-27
CA2294614C (en) 2002-01-08
CN1134432C (zh) 2004-01-14
EP1186602A2 (de) 2002-03-13
SA98190410B1 (ar) 2006-06-10
PT991641E (pt) 2003-06-30
CN1261362A (zh) 2000-07-26
RU2186778C2 (ru) 2002-08-10
TR199903270T2 (xx) 2000-07-21
MY127871A (en) 2006-12-29
EG24224A (en) 2008-11-10
HK1026699A1 (en) 2000-12-22
US6207188B1 (en) 2001-03-27
IS5314A (is) 1999-12-21
IS1946B (is) 2004-10-13
SK283958B6 (sk) 2004-06-08
KR20010014165A (ko) 2001-02-26
SE510643C2 (sv) 1999-06-14
TW483758B (en) 2002-04-21
JP3377218B2 (ja) 2003-02-17
EP0991641A1 (de) 2000-04-12
NO996440D0 (no) 1999-12-23
PL190869B1 (pl) 2006-02-28
JP2001508805A (ja) 2001-07-03
IL133559A0 (en) 2001-04-30
EP0991641B1 (de) 2003-03-05
EP1186602A3 (de) 2002-03-27
KR100580987B1 (ko) 2006-05-17
EE9900593A (et) 2000-08-15
CZ469999A3 (cs) 2000-08-16
ID24829A (id) 2000-08-24
AU750239B2 (en) 2002-07-11
UA58556C2 (uk) 2003-08-15
NO318245B1 (no) 2005-02-21
NZ501929A (en) 2001-06-29
AR013350A1 (es) 2000-12-27
SE9702483L (sv) 1998-12-28
BR9810483A (pt) 2000-09-12
WO1999000380A1 (en) 1999-01-07
ZA985317B (en) 1999-01-11
HUP0003017A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
ATE233756T1 (de) Kristalline form von omeprazol-natriumsalz
ATE239011T1 (de) Neuartige form von s-omeprazol
DE69941116D1 (de) G von gdf-8
ID16866A (id) Kompleks kompleks inklusi garam-garam aril-heterosiklik
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
EE200000031A (et) Uued spiroasabitsüklilised heterotsüklilised ühendid
DE60004317D1 (de) Salze von Sulfonium-Verbindungen
IS5989A (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
DE69905054D1 (de) KRISTALLINE FORMEN VON EtO2C-CH2-(R)Cgl-Aze-Pab-OH
DK44888D0 (da) Natriumsalt af 5-chlor-3-(2-thenoyl)-2-oxindol-1-carboxamid
EE04154B1 (et) Omeprasooli valmistamise meetod
ATE339438T1 (de) Substanziell kristalline form von melagatran
ATE241275T1 (de) Phosphoniumsalz-zusammensetzung
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
EE200100381A (et) Morfolinobensamiidi uued soolad
ATE311364T1 (de) Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid
SI0991641T1 (en) Crystalline form of omeprazole sodium salt
ID26940A (id) Garam fosfat isopropil-metil-[2-(3-n-propoksifenoksi)-etil] amina
BR1100811A (pt) Derivados de 1-metil-carbapenema

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0991641

Country of ref document: EP